BUY Marksans Pharma Limited — Sachin Gupta
bySachin GuptaHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active intraday BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·23 Sept · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Marksans Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services29 Sept 2026 · ~2 weeks · target ₹380 · SL hit
- BUY — IDBI Capital29 Sept 2026 · ~3 months · target ₹380 · SL hit
- BUY — Rajesh Satpute29 Sept 2026 · ~2 weeks · target ₹360 · SL hit
- BUY — Kunal Saraogi24 Sept 2026 · Same day · target ₹356 · SL hit
- BUY — Vinay Rajani, HDFC Securities24 Sept 2026 · ~2 weeks · target ₹370 · SL hit
More from Sachin Gupta
- BUY Yatharth Hospital & Trauma Care Services4 Nov 2026 · ~2 weeks · target ₹1,070 · Active
- BUY HDFC Asset Management Company4 Nov 2026 · ~3 months · target ₹2,650 · Active
- BUY BEML4 Nov 2026 · ~2 weeks · target ₹2,166 · SL hit
- BUY One 97 Communications29 Oct 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY FSN E-Commerce Ventures29 Oct 2026 · ~2 weeks · target ₹370 · Active

